A Phase 2, Randomized, Double-Blind, Vehicle Controlled, Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis
Latest Information Update: 26 Aug 2021
Price :
$35 *
At a glance
- Drugs Glycopyrrolate (Primary)
- Indications Hyperhidrosis
- Focus Therapeutic Use
- Sponsors Dermira
- 12 Jan 2021 Results assessing relationship between glycopyrronium pharmacokinetics and anticholinergic-related adverse events or efficacy with population pharmacokinetics using data from two phase II studies published in the Clinical Pharmacokinetics
- 17 Mar 2017 According to a Dermira media release, data from this study will be presented at 13th Annual Maui Derm for Dermatologists 2017 meeting.
- 05 Feb 2015 Results published in the Media Release.